What is the duration of the treatment effect of Lokomat (robot-assisted gait training) for stroke patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Treatment Effect for Lokomat in Stroke Patients

The treatment effects of Lokomat robotic-assisted gait training for stroke patients typically begin to diminish after 8-12 weeks without continued therapy, requiring maintenance interventions to sustain the gains. 1

Factors Affecting Duration of Treatment Effect

Evidence from Guidelines

  • According to the AHA/ASA guidelines, improvements in gait velocity from intensive gait-focused therapy at 6 weeks were not sustained at 3 and 6 months follow-up 1
  • The long-term sustainability of gains from mechanically assisted walking devices like Lokomat remains uncertain according to current guidelines 2, 1

Training Parameters That Affect Durability

  • Intensity: Higher intensity training (77%-95% of maximal heart rate) leads to more durable improvements 1
  • Frequency: At least three sessions per week 1
  • Duration: Sessions of at least 30 minutes and program duration of 12 weeks are recommended for more lasting effects 1
  • Phase of Recovery: Patients in subacute phase may show better retention of gains than those in chronic phases 1

Maintenance Strategies to Prolong Effects

Combination Approaches

  • Combining Lokomat with conventional physical therapy shows better long-term outcomes than either intervention alone 3
  • Integrating strengthening exercises, balance training, and functional electrical stimulation may enhance durability 1

Continued Rehabilitation

  • The AHA/ASA guidelines strongly imply that continuing with conventional physical therapy after Lokomat training is necessary to maintain gains 2, 1
  • Rehabilitation should continue for as long as the patient continues to achieve treatment goals, even after hospital discharge 1

Clinical Considerations

Monitoring for Decline

  • Regular follow-up assessments using standardized measures (Timed Up and Go Test, 10-meter Walking Test, Functional Ambulation Categories) can help detect early decline in function 3
  • When decline is noted, a "booster" course of Lokomat training may be beneficial, though this is not explicitly studied in the literature

Patient-Specific Factors

  • Stroke severity and baseline functional status affect the durability of treatment effects 1
  • Psychological benefits from Lokomat training (improved well-being and coping) may persist longer than physical improvements 4

Common Pitfalls

  • Relying solely on Lokomat without complementary conventional therapy may lead to faster decline in function 1
  • Insufficient training intensity or duration (less than 12 weeks) may result in shorter-lasting effects 1
  • Failing to continue with some form of maintenance therapy after the initial Lokomat program typically results in regression of gains within 2-3 months 2, 1

In conclusion, while Lokomat provides significant benefits for stroke rehabilitation, these benefits require ongoing maintenance through continued therapy interventions to prevent decline after the initial 8-12 week period.

References

Guideline

Lokomat Robotic-Assisted Gait Training Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Robotic neurorehabilitation in patients with chronic stroke: psychological well-being beyond motor improvement.

International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.